Literature DB >> 27354427

Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension.

Nathan P Rudemiller1, Steven D Crowley2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27354427      PMCID： PMC4945449          DOI： 10.1161/HYPERTENSIONAHA.116.06591

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  91 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Preventing autoimmunity protects against the development of hypertension and renal injury.

Authors:  Keisa W Mathis; Kedra Wallace; Elizabeth R Flynn; Christine Maric-Bilkan; Babbette LaMarca; Michael J Ryan
Journal:  Hypertension       Date:  2014-07-14       Impact factor: 10.190

3.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

4.  Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1.

Authors:  John T Parissis; Socrates Korovesis; Elefterios Giazitzoglou; Pericles Kalivas; Demosthenes Katritsis
Journal:  Int J Cardiol       Date:  2002-04       Impact factor: 4.164

5.  Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.

Authors:  Christopher T Chan; Jeffrey P Moore; Klaudia Budzyn; Elizabeth Guida; Henry Diep; Antony Vinh; Emma S Jones; Robert E Widdop; James A Armitage; Samy Sakkal; Sharon D Ricardo; Christopher G Sobey; Grant R Drummond
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

Review 6.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

7.  Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis.

Authors:  Jian-dong Zhang; Mehul B Patel; Robert Griffiths; Paul C Dolber; Phillip Ruiz; Matthew A Sparks; Johannes Stegbauer; Huixia Jin; Jose A Gomez; Anne F Buckley; William S Lefler; Daian Chen; Steven D Crowley
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

8.  Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy.

Authors:  Srinivas Sriramula; Masudul Haque; Dewan S A Majid; Joseph Francis
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.

Authors:  Ahmed A Elmarakby; Jeffrey E Quigley; Jeffrey J Olearczyk; Aarthi Sridhar; Anthony K Cook; Edward W Inscho; David M Pollock; John D Imig
Journal:  Hypertension       Date:  2007-10-15       Impact factor: 10.190

10.  Patients with essential hypertension present higher levels of sE-selectin and sVCAM-1 than normotensive volunteers.

Authors:  Iván Palomo; Patricio Marín; Marcelo Alarcón; Gilda Gubelin; Ximena Viñambre; Eduardo Mora; Gloria Icaza
Journal:  Clin Exp Hypertens       Date:  2003-11       Impact factor: 1.749
View more
  25 in total

1.  C-C Motif Chemokine Receptor 7 Exacerbates Hypertension Through Effects on T Lymphocyte Trafficking.

Authors:  Yi Wen; Nathan P Rudemiller; Jiandong Zhang; Xiaohan Lu; Jiafa Ren; Jamie R Privratsky; Robert Griffiths; Junyi J Zhang; Gianna E Hammer; Steven D Crowley
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

Review 2.  Salt, Hypertension, and Immunity.

Authors:  A Justin Rucker; Nathan P Rudemiller; Steven D Crowley
Journal:  Annu Rev Physiol       Date:  2017-11-16       Impact factor: 19.318

Review 3.  Role of complement 3 in the pathogenesis of hypertension.

Authors:  Lan Chen; Noboru Fukuda; Taro Matsumoto; Masanori Abe
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

Review 4.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 5.  The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.

Authors:  Revathy Carnagarin; Vance Matthews; Maria T K Zaldivia; Karlheinz Peter; Markus P Schlaich
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

Review 6.  The role of macrophages in hypertension and its complications.

Authors:  A Justin Rucker; Steven D Crowley
Journal:  Pflugers Arch       Date:  2017-03-01       Impact factor: 3.657

Review 7.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 8.  Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology.

Authors:  Satoru Eguchi; Tatsuo Kawai; Rosario Scalia; Victor Rizzo
Journal:  Hypertension       Date:  2018-03-26       Impact factor: 10.190

Review 9.  Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure.

Authors:  Ryousuke Satou; Harrison Penrose; L Gabriel Navar
Journal:  Curr Hypertens Rep       Date:  2018-10-05       Impact factor: 5.369

10.  Circulating choline is associated with coronary artery stenosis in patients with hypertension: A cross-sectional study of Chinese adults.

Authors:  Fei Guo; Xueting Qiu; Yuanting Zhu; Zhirong Tan; Zhenyu Li; Dongsheng Ouyang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-23       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.